Report copyright - Novel Oral Anti-coagulants in Patients with Malignancy...Novel Oral Anticoagulants in Patients with Malignancy •Dabigatran (Pradaxa), Rivaroxaban (Xarelto), Apixaban (Eliquis) •Approved
Please pass captcha verification before submit form